CYN Cyngn Inc.
Nasdaq · SEC CIK 1874097 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 29 since 2021-10-22, latest 2024-05-03
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 18
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-03 | 2024-05-01 | CYN | McDonnell James | Dir | A - Grant | $0.00 | +72.0K | 189.5K | +61% | $0 | |
| 2024-05-03 | 2024-05-01 | CYN | Cunningham Colleen | Dir | A - Grant | $0.00 | +72.0K | 189.5K | +61% | $0 | |
| 2024-05-03 | 2024-05-01 | CYN | Macleod Karen M | Dir | A - Grant | $0.00 | +72.0K | 190.8K | +61% | $0 | |
| 2023-05-31 | 2023-05-27 | CYN | McDonnell James | Dir | A - Grant | $0.00 | +36.0K | 117.5K | +44% | $0 | |
| 2023-05-31 | 2023-05-27 | CYN | Cunningham Colleen | Dir | A - Grant | $0.00 | +36.0K | 117.5K | +44% | $0 | |
| 2023-05-31 | 2023-05-27 | CYN | Macleod Karen M | Dir | A - Grant | $0.00 | +36.0K | 118.8K | +43% | $0 | |
| 2023-04-04 | 2023-03-31 | CYN | Macleod Karen M | Dir | P - Purchase | $1.23 | +1,250 | 50.2K | +3% | +$1,538 | |
| D | 2022-08-01 | 2022-07-27 | CYN | Landen Ben | VP of Business Development | M - OptEx | $0.23 | +40.0K | 40.0K | New | +$9,200 |
| 2022-07-20 | 2022-07-13 | CYN | Macleod Karen M | Dir | A - Grant | $0.00 | +2,717 | 48.9K | +6% | $0 | |
| 2022-07-20 | 2022-07-13 | CYN | Cunningham Colleen | Dir | A - Grant | $0.00 | +2,717 | 48.9K | +6% | $0 | |
| 2022-07-20 | 2022-07-13 | CYN | McDonnell James | Dir | A - Grant | $0.00 | +2,717 | 48.9K | +6% | $0 | |
| D | 2022-02-03 | 2022-02-02 | CYN | Tal Lior | CEO, Dir, 10% | M - OptEx | $0.13 | +500.0K | 500.0K | New | +$65.0K |
| DM | 2021-10-26 | 2021-10-22 | CYN | Redpoint Ventures IV, L.P. | 10% | C - Cnv Deriv | — | +2.40M | 2.27M | New | — |
| DMI | 2021-10-26 | 2021-10-22 | CYN | Redpoint Ventures IV, L.P. | 10% | C - Cnv Deriv | — | +61.6K | 58.2K | New | — |
| DMI | 2021-10-22 | 2021-10-22 | CYN | GURLEY J WILLIAM | 10% | C - Cnv Deriv | — | +9.24M | 8.04M | New | — |
| DMI | 2021-10-22 | 2021-10-22 | CYN | LASKY MITCHELL | Dir, 10% | C - Cnv Deriv | — | +9.24M | 8.73M | New | — |
| DMI | 2021-10-22 | 2021-10-22 | CYN | Andreessen Horowitz Fund III, L.P. | 10% | C - Cnv Deriv | — | +5.23M | 4.95M | New | — |
| DMI | 2021-10-22 | 2021-10-22 | CYN | Benchmark Capital Partners VII, L.P. | 10% | C - Cnv Deriv | — | +9.24M | 8.73M | New | — |
Purchase Sale Sale after option exercise All abbreviations